AAPL.SN
Apple Inc.
SantiagoUSDEQUITY
Technology
DELAYED
Last price
307.92
▲ 2.33 (0.76%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
305.59
Day high
307.92
Day low
307.92
Volume
15
Market cap
$4.49T
P/E (TTM)
35.31
52W range
228.19 – 315.58
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
0.00%
-3.7%
3M
+5.29%
+2.2%
6M
+26.19%
+15.1%
YTD
+16.01%
+3.7%
1Y
+36.69%
+16.7%
3Y
+60.77%
-13.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on AAPL.SN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
240.51M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 11, 26 | NEWSTEAD JENNIFER General Counsel |
SELL | 1.44K | $442.85K | Direct |
| Jun 16, 26 | BORDERS BEN Officer |
SELL | 116 | $34.24K | Direct |
| Jun 15, 26 | NEWSTEAD JENNIFER General Counsel |
— | 30.10K | — | Direct |
| Jun 15, 26 | BORDERS BEN Officer |
— | 240 | — | Direct |
| May 27, 26 | LEVINSON ARTHUR D Director |
STOCK | 65.00K | $0 | Direct |
| May 27, 26 | LEVINSON ARTHUR D Director |
SELL | 50.00K | $15.55M | Direct |
| May 8, 26 | BORDERS BEN Officer |
SELL | 1.27K | $369.46K | Direct |
| May 6, 26 | LEVINSON ARTHUR D Director |
STOCK | 5.00K | $0 | Direct |
| May 6, 26 | LEVINSON ARTHUR D Director |
SELL | 250.00K | $71.19M | Direct |
| Apr 23, 26 | PAREKH KEVAN Chief Financial Officer |
SELL | 1.53K | $421.85K | Direct |
| Apr 15, 26 | PAREKH KEVAN Chief Financial Officer |
— | 10.93K | — | Direct |
| Apr 15, 26 | BORDERS BEN Officer |
— | 1.72K | — | Direct |
| Apr 2, 26 | COOK TIMOTHY D Chief Executive Officer |
SELL | 64.95K | $16.51M | Direct |
| Apr 2, 26 | O'BRIEN DEIRDRE Officer |
SELL | 30.00K | $7.66M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ADAMS KATHERINE L |
General Counsel | 175.41K | Stock Gift |
COOK TIMOTHY D |
Chief Executive Officer | 3.28M | Sale |
JUNG ANDREA |
Director | 77.66K | Conversion of Exercise of derivative security |
KHAN SABIH |
Chief Operating Officer | 1.11M | Conversion of Exercise of derivative security |
LEVINSON ARTHUR D |
Director | 3.76M | Stock Gift |
MAESTRI LUCA |
Chief Financial Officer | 107.79K | Sale |
O'BRIEN DEIRDRE |
Officer | 136.81K | Sale |
SUGAR RONALD D |
Director | 110.57K | Conversion of Exercise of derivative security |
WAGNER SUSAN L |
Director | 69.79K | Conversion of Exercise of derivative security |
WILLIAMS JEFFREY E |
Chief Operating Officer | 390.06K | Sale |
Fundamentals
Market cap$4.49T
Enterprise value$4.48T
Revenue (TTM)$466.82B
Gross profit$227.12B
EBITDA$167.96B
Net income$128.93B
EPS (TTM)$8.72
Free cash flow$107.72B
Total cash$62.40B
Total debt$84.34B
Book value / share$7.36
Shares outstanding14.59B
Float14.57B
Short % of float—
Dividend yield0.34%
Beta (5Y)1.09
Valuation & profitability ratios
Trailing P/E35.31
Forward P/E—
PEG ratio2.53
Price / sales—
Price / book41.84
EV / revenue9.60
EV / EBITDA26.68
Gross margin48.65%
Operating margin32.62%
Profit margin27.62%
Return on equity148.75%
Return on assets27.08%
Debt / equity78.45
Current ratio1.00
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $416.16B | $391.04B | $383.29B | $394.33B | — | +6.4% |
| Operating revenue | $416.16B | $391.04B | $383.29B | $394.33B | — | +6.4% |
| Cost of revenue | $220.96B | $210.35B | $214.14B | $223.55B | — | +5.0% |
| Gross profit | $195.20B | $180.68B | $169.15B | $170.78B | — | +8.0% |
| Research & development | $34.55B | $31.37B | $29.91B | $26.25B | — | +10.1% |
| Selling, general & admin | $27.60B | $26.10B | $24.93B | $25.09B | — | +5.8% |
| Total operating expense | $62.15B | $57.47B | $54.85B | $51.34B | — | +8.2% |
| Operating income | $133.05B | $123.22B | $114.30B | $119.44B | — | +8.0% |
| Net interest income | — | — | -$183.00M | -$106.00M | $198.00M | — |
| Pre-tax income | $132.73B | $123.48B | $113.74B | $119.10B | — | +7.5% |
| Tax provision | $20.72B | $29.75B | $16.74B | $19.30B | — | -30.4% |
| Net income | $112.01B | $93.74B | $97.00B | $99.80B | — | +19.5% |
| Net income to common | $112.01B | $93.74B | $97.00B | $99.80B | — | +19.5% |
| Basic EPS | 7.49 | 6.11 | 6.16 | 6.15 | — | +22.6% |
| Diluted EPS | 7.46 | 6.08 | 6.13 | 6.11 | — | +22.7% |
| EBIT | $133.05B | $123.22B | $114.30B | $119.44B | — | +8.0% |
| EBITDA | $144.75B | $134.66B | $125.82B | $130.54B | — | +7.5% |
| Basic shares | 14.95B | 15.34B | 15.74B | 16.22B | — | -2.6% |
| Diluted shares | 15.00B | 15.41B | 15.81B | 16.33B | — | -2.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $35.93B | $29.94B | $29.96B | $23.65B | +20.0% |
| Cash & short-term investments | $54.70B | $65.17B | $61.55B | $48.30B | -16.1% |
| Accounts receivable | $39.78B | $33.41B | $29.51B | $28.18B | +19.1% |
| Inventory | $5.72B | $7.29B | $6.33B | $4.95B | -21.5% |
| Total current assets | $147.96B | $152.99B | $143.57B | $135.41B | -3.3% |
| Property, plant & equipment | $49.83B | $45.68B | $43.72B | $42.12B | +9.1% |
| Total assets | $359.24B | $364.98B | $352.58B | $352.75B | -1.6% |
| Total current liabilities | $165.63B | $176.39B | $145.31B | $153.98B | -6.1% |
| Current debt | $20.33B | $20.88B | $15.81B | $21.11B | -2.6% |
| Long-term debt | $78.33B | $85.75B | $95.28B | $98.96B | -8.7% |
| Total debt | $98.66B | $106.63B | $111.09B | $132.48B | -7.5% |
| Total liabilities | $285.51B | $308.03B | $290.44B | $302.08B | -7.3% |
| Retained earnings | -$14.26B | -$19.15B | -$214.00M | -$3.07B | +25.5% |
| Shareholder equity | $73.73B | $56.95B | $62.15B | $50.67B | +29.5% |
| Working capital | -$17.67B | -$23.41B | -$1.74B | -$18.58B | +24.5% |
| Net tangible assets | $73.73B | $56.95B | $62.15B | $50.67B | +29.5% |
| Shares issued | 14.77B | 15.12B | 15.55B | 15.94B | -2.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $112.01B | $93.74B | $97.00B | $99.80B | +19.5% |
| Depreciation & amortisation | $11.70B | $11.45B | $11.52B | $11.10B | +2.2% |
| Stock-based compensation | $12.86B | $11.69B | $10.83B | $9.04B | +10.1% |
| Change in working capital | -$25.00B | $3.65B | -$6.58B | $1.20B | -784.7% |
| Operating cash flow | $111.48B | $118.25B | $110.54B | $122.15B | -5.7% |
| Capital expenditure | -$12.71B | -$9.45B | -$10.96B | -$10.71B | -34.6% |
| Investing cash flow | $15.20B | $2.94B | $3.71B | -$22.35B | +417.7% |
| Share buybacks | -$90.71B | -$94.95B | -$77.55B | -$89.40B | +4.5% |
| Dividends paid | -$15.42B | -$15.23B | -$15.03B | -$14.84B | -1.2% |
| Financing cash flow | -$120.69B | -$121.98B | -$108.49B | -$110.75B | +1.1% |
| Free cash flow | $98.77B | $108.81B | $99.58B | $111.44B | -9.2% |
| End cash position | $35.93B | $29.94B | $30.74B | $24.98B | +20.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $109.42B | $111.18B | $143.76B | $102.47B | $94.04B | — | -1.6% |
| Operating revenue | $109.42B | $111.18B | $143.76B | $102.47B | $94.04B | — | -1.6% |
| Cost of revenue | $54.65B | $56.40B | $74.53B | $54.13B | $50.32B | — | -3.1% |
| Gross profit | $54.77B | $54.78B | $69.23B | $48.34B | $43.72B | — | -0.0% |
| Research & development | $11.73B | $11.42B | $10.89B | $8.87B | $8.87B | — | +2.7% |
| Selling, general & admin | $7.35B | $7.48B | $7.49B | $7.05B | $6.65B | — | -1.8% |
| Total operating expense | $19.07B | $18.90B | $18.38B | $15.91B | $15.52B | — | +0.9% |
| Operating income | $35.70B | $35.88B | $50.85B | $32.43B | $28.20B | — | -0.5% |
| Pre-tax income | $36.27B | $35.83B | $51.00B | $32.80B | $28.03B | — | +1.2% |
| Tax provision | $6.48B | $6.25B | $8.90B | $5.34B | $4.60B | — | +3.6% |
| Net income | $29.79B | $29.58B | $42.10B | $27.47B | $23.43B | — | +0.7% |
| Net income to common | $29.79B | $29.58B | $42.10B | $27.47B | $23.43B | — | +0.7% |
| Basic EPS | 2.03 | 2.02 | 2.85 | — | 1.57 | 1.65 | +0.5% |
| Diluted EPS | 2.02 | 2.01 | 2.84 | — | 1.57 | 1.65 | +0.5% |
| EBIT | $35.70B | $35.88B | $50.85B | $32.43B | $28.20B | — | -0.5% |
| EBITDA | $39.02B | $39.32B | $54.07B | $35.55B | $31.03B | — | -0.8% |
| Basic shares | 14.66B | 14.67B | 14.75B | — | 14.90B | 14.99B | -0.1% |
| Diluted shares | 14.71B | 14.73B | 14.81B | — | 14.95B | 15.06B | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $39.54B | $45.57B | $45.32B | $35.93B | $36.27B | -13.2% |
| Cash & short-term investments | $62.40B | $68.51B | $66.91B | $54.70B | $55.37B | -8.9% |
| Accounts receivable | $31.40B | $30.34B | $39.92B | $39.78B | $27.56B | +3.5% |
| Inventory | $11.09B | $6.75B | $5.88B | $5.72B | $5.92B | +64.4% |
| Total current assets | $149.82B | $144.11B | $158.10B | $147.96B | $122.49B | +4.0% |
| Property, plant & equipment | $51.43B | $50.12B | $50.16B | $49.83B | $48.51B | +2.6% |
| Goodwill & intangibles | $20.34B | $21.33B | — | — | — | -4.6% |
| Total assets | $383.27B | $371.08B | $379.30B | $359.24B | $331.50B | +3.3% |
| Total current liabilities | $149.33B | $134.64B | $162.37B | $165.63B | $141.12B | +10.9% |
| Current debt | $13.00B | $10.31B | $13.82B | $20.33B | $19.27B | +26.2% |
| Long-term debt | $71.34B | $74.40B | $76.69B | $78.33B | $82.43B | -4.1% |
| Total debt | $84.34B | $84.71B | $90.51B | $98.66B | $101.70B | -0.4% |
| Total liabilities | $275.75B | $264.59B | $291.11B | $285.51B | $265.67B | +4.2% |
| Retained earnings | $11.33B | $12.36B | -$2.18B | -$14.26B | -$17.61B | -8.4% |
| Shareholder equity | $107.52B | $106.49B | $88.19B | $73.73B | $65.83B | +1.0% |
| Working capital | $492.00M | $9.47B | -$4.26B | -$17.67B | -$18.63B | -94.8% |
| Net tangible assets | $87.18B | $85.16B | $88.19B | $73.73B | $65.83B | +2.4% |
| Shares issued | 14.69B | 14.67B | 14.70B | 14.77B | 14.86B | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $29.79B | $29.58B | $42.10B | $27.47B | $23.43B | +0.7% |
| Depreciation & amortisation | $3.32B | $3.44B | $3.21B | $3.13B | $2.83B | -3.5% |
| Stock-based compensation | $3.40B | $3.53B | $3.59B | $3.18B | $3.17B | -3.6% |
| Change in working capital | -$1.82B | -$6.65B | $5.55B | -$5.71B | -$2.03B | +72.6% |
| Operating cash flow | $34.37B | $28.70B | $53.92B | $29.73B | $27.87B | +19.7% |
| Capital expenditure | -$2.46B | -$1.97B | -$2.37B | -$3.24B | -$3.46B | -24.6% |
| Investing cash flow | -$7.76B | -$6.17B | -$4.89B | -$2.59B | $5.07B | -25.8% |
| Share buybacks | -$25.11B | -$12.29B | -$24.70B | -$20.13B | -$21.07B | -104.3% |
| Dividends paid | -$4.04B | -$3.82B | -$3.92B | -$3.86B | -$3.94B | -5.6% |
| Financing cash flow | -$32.64B | -$22.28B | -$39.66B | -$27.48B | -$24.83B | -46.5% |
| Free cash flow | $31.91B | $26.73B | $51.55B | $26.49B | $24.41B | +19.4% |
| End cash position | $39.54B | $45.57B | $45.32B | $35.93B | $36.27B | -13.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $113.55B | +10.8% |
| Next quarter | — | — | $154.43B | +7.4% |
| Current year | — | — | $477.68B | +14.8% |
| Next year | — | — | $525.00B | +9.9% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders1.65%
Held by institutions66.42%
Institutions holding7.73K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
313.76
-1.86% from price
SMA 20
313.76
0.00% from price
SMA 50
308.63
+1.66% from price
SMA 100
292.23
+5.37% from price
SMA 200
277.23
+13.18% from price
EMA 12
313.70
-1.84% from price
EMA 26
312.42
-1.44% from price
EMA 50
307.40
+0.17% from price
RSI (14)
97.3
Overbought
MACD (12,26,9)
1.28
Hist -0.50
ATR (14)
0.00
—
Realised vol 30D
0.7%
Annualised
Bollinger upper
313.76
20, 2σ
Bollinger lower
313.76
20, 2σ
50 / 200 cross
Golden
308.63 vs 277.23
Trend bias
Above 200
+13.18%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.10
Less volatile than market
Correlation to SPY
-0.06
Largely independent
Realised vol 30D
0.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-10.5%
Peak to trough
Max drawdown 5Y
-30.5%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
1.09
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 10, 26 | Jefferies | DOWNGRADE | Hold | Underperform |
| Aug 4, 26 | China Renaissance | DOWNGRADE | Buy | Hold |
| Jul 31, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 31, 26 | DA Davidson | MAINTAINED | Neutral | Neutral |
| Jul 31, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Needham | MAINTAINED | Hold | Hold |
| Jul 31, 26 | Rosenblatt | MAINTAINED | Neutral | Neutral |
| Jul 31, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| Jul 31, 26 | Goldman Sachs | MAINTAINED | Buy | Buy |
| Jul 31, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jul 23, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate$1.08 / yr
Forward yield0.34%
5-year avg yield0.50%
Payout ratio12.04%
Ex-dividend dateAug 10, 2026
Next pay date—
Last split4:1
Split dateAug 31, 2020
Headlines
147 Laps Around the Mall: Washington Hosts Freedom 250 Street Race
The Wall Street Journal · 9m ago
After Buying Circle Through a 42% Drop, Cathie Wood Says Analysts Cannot Fathom It
BeInCrypto · 10m ago
BC-Nikkei 225 Futures
Associated Press · 10m ago
Hugging Face exploring sale valuing it at $13 billion, Business Insider says
Reuters · 10m ago
Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?
Insider Monkey · 13m ago
Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?
Insider Monkey · 16m ago
The Committee for a Responsible Federal Budget Estimates Social Security Cuts for Couples if the System Is Not Fixed
Motley Fool · 20m ago
Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?
Insider Monkey · 21m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.